From: Heterogeneity of mammary lesions represent molecular differences
Name | GO ID | Corrected P-value |
---|---|---|
Spindle/Microtubule | Â | Â |
   mitotic spindle organization and biogenesis | GO:0007052 | 0.00E+00 |
   spindle organization and biogenesis | GO:0007051 | 0.00E+00 |
   microtubule cytoskeleton organization and biogenesis | GO:0000226 | 0.00E+00 |
   microtubule-based movement | GO:0007018 | 4.70E-07 |
   chromosome segregation | GO:0007059 | 4.32E-03 |
   microtubule polymerization | GO:0046785 | 1.59E-02 |
   microtubule polymerization or depolymerization | GO:0031109 | 1.97E-02 |
   M phase specific microtubule process | GO:0000072 | 3.32E-02 |
Cell cycle | Â | Â |
   regulation of mitosis | GO:0007088 | 0.00E+00 |
   cell cycle checkpoint | GO:0000075 | 0.00E+00 |
   interphase of mitotic cell cycle | GO:0051329 | 0.00E+00 |
   G1/S transition of mitotic cell cycle | GO:0000082 | 0.00E+00 |
   negative regulation of cell cycle | GO:0045786 | 6.08E-03 |
   G2/M transition of mitotic cell cycle | GO:0000086 | 1.29E-02 |
   mitotic checkpoint | GO:0007093 | 1.28E-02 |
   regulation of cyclin dependent protein kinase activity | GO:0000079 | 1.25E-02 |
   G1 phase of mitotic cell cycle | GO:0000080 | 1.41E-02 |
   traversing start control point of mitotic cell cycle | GO:0007089 | 1.67E-02 |
   cell cycle arrest | GO:0007050 | 1.67E-02 |
   mitotic anaphase | GO:0000090 | 2.63E-02 |
   anaphase | GO:0051322 | 2.72E-02 |
   prophase | GO:0051324 | 2.81E-02 |
Angiogenesis | Â | Â |
   blood vessel morphogenesis | GO:0048514 | 6.37E-03 |
   angiogenesis | GO:0001525 | 1.01E-02 |
   blood vessel development | GO:0001568 | 9.73E-03 |
Steroid | Â | Â |
   steroid biosynthesis | GO:0006694 | 3.45E-02 |